Watch: Zyon Ayni Muay Thai Training with Saenchai
Zyon Ayni, the 48-year-old Israeli-Dutch entrepreneur and CEO of Code Pharma, won the Hua Hin Muay Thai Championship after defeating local champion Pet Pai Lin.
April 25, 2022
Author: Zyon Ayni - Site Team
“Codivir Showed Great Success in Clinical Trials”
Zyon Ayni, Founder and CEO of Code Pharma, was quoted on TradeArabia: “Codivir showed great success in clinical trials and already has received emergency approvals
January 31, 2022
Ynet: Interview about Code Pharma and Codivir
Code Pharma and its Founder and CEO, Zyon Ayni, invented Codivir, an antiviral medicine against COVID-19. “We have worked with patients in Africa and we
January 25, 2022
“Codivir Performs Well Against Mutations” | IssueWire
Code Pharma CEO and Founder, Zyon Ayni, said in a press release on IssueWire: “scientific data on Codivir’s mechanism of action has proven strongly that
December 9, 2021
“An Exciting Day for the Code Pharma Team” | Yahoo Finance
Yahoo Finance published an article about Code Pharma and its intention to launch an Initial Public Offering (IPO) and list its shares on the NASDAQ
November 30, 2021
Zyon Ayni on Pressat: “Codivir is the Antibiotic of the Viruses”
Zyon Ayni, Founder and CEO of Code Pharma, tells Pressat about Codivir: “The company is preparing for a massive Phase II trial, which will be
October 28, 2021
Zyon Ayni: “To Eliminate the Virus, I Need One More Miracle and Lot Of Hard Training”
Global Trend Monitor Magazine published an interview with Zyon Ayni, Founder and CEO of Code Pharma. Ayni explained about the medication Codivir: “Codivir is a
October 5, 2021
Zyon Ayni: “The World Is in Need of An Antiviral Medication Against COVID”
The Jerusalem Post published an article about Codivir, A drug used to treat HIV and has a direct antiviral effect on coronavirus. According to Code
September 15, 2021
Codivir Appears To Be Effective Against COVID-19 | Yahoo News
Code Pharma, a Dutch pharmaceutical company, is mentioned in an article on Yahoo News. The company is developing a direct antiviral drug against COVID-19. After
September 5, 2021